Overview
- HeadquartersSan Diego, United States2
- Incorporated inDE3
- Business address4747 Executive Drive, Suite 210, San Diego, Ca 921213
- Legal formLimited Partnership2
- Kind of organizationLimited partnership2
- LEI254900C0FTELHTMZ1C332
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 35594052
Corporate structure
TANG CAPITAL PARTNERS LP sits at the top of its group. 59 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- TANG CAPITAL PARTNERS LP San Diego, California, United States
- Jounce Therapeutics Las Vegas, Nevada, United States
- TLGFY, LLC San Diego, California, United States
- Aclaris Therapeutics, Inc. Stake · Wayne, Pennsylvania, United States
- Adicet Bio, Inc. Stake · Boston, Massachusetts
- AGILE THERAPEUTICS INC Stake · Princeton, New Jersey, United States
- ALBIREO PHARMA, INC. Stake · Boston, Massachusetts, United States
- Aligos Therapeutics, Inc. Stake · South San Francisco, California, United States
- Altimmune, Inc. Stake · Gaithersburg, Maryland, United States
- ALX ONCOLOGY HOLDINGS INC Stake · South San Francisco, California
- ANAPTYSBIO, INC Stake · San Diego, California, United States
- Aptevo Therapeutics Inc. Stake · Wilmington, Delaware, United States
- ASLAN Pharmaceuticals Ltd Stake · Singapore, Singapore
- Atea Pharmaceuticals, Inc. Stake · Boston, Massachusetts
- aTyr Pharma Stake · San Diego, California, United States
- Bellerophon Therapeutics (United States) Stake · Warren
- BioAtla Stake · San Diego
- bluebird bio Stake · Cambridge
- Bolt Biotherapeutics, Inc. Stake · Redwood City, California, United States
- Canton Strategic Holdings, Inc. Stake · New York, New York
- Corbus Pharmaceuticals Stake · Norwood, Massachusetts, United States
- Corvus Pharmaceuticals, Inc. Stake · Burlingame, California, United States
- CytomX Therapeutics, Inc. Stake · South San Francisco, California, United States
- Elevation Oncology, Inc. Stake · Boston, Massachusetts
- Evolus, Inc. Stake · Newport Beach, California, United States
- Genfit S.A. Stake · I0
- and 33 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (56 companies). Each entity in the chart links to its source.
Subsidiaries and ownership
Also consolidated
Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.
Timeline
- Aug 16, 2002Founded TANG CAPITAL PARTNERS LP is founded2
Stakes it holds
TANG CAPITAL PARTNERS LP has told the SEC it owns more than 5% of 56 companies, latest first (Schedules 13D and 13G).
- ALX ONCOLOGY HOLDINGS INCSCHEDULE 13G/A Aug 22, 2024 to Feb 14, 20256
- Marinus Pharmaceuticals (United States)SCHEDULE 13G/A Apr 19, 2024 to Feb 14, 20257
- Outlook Therapeutics, Inc.SCHEDULE 13G/A Mar 28, 2024 to Feb 14, 20258
- OnKure Therapeutics, Inc.SC 13G Dec 26, 2023 to Sep 26, 20249
- AGILE THERAPEUTICS INCSC 13G Jul 22, 202410
- HilleVax, Inc.SC 13G Jul 22, 202411
- Theseus Pharmaceuticals, Inc.SC 13D/A Nov 24, 2023 to Feb 16, 202412
- ANAPTYSBIO, INCSC 13G/A Feb 14, 202413
- Aclaris Therapeutics, Inc.SC 13G/A Nov 24, 2023 to Feb 14, 202414
- Adicet Bio, Inc.SC 13G/A Mar 13, 2023 to Feb 14, 202415
- Aligos Therapeutics, Inc.SC 13G/A Dec 27, 2022 to Feb 14, 202416
- Altimmune, Inc.SC 13G/A Mar 24, 2022 to Feb 14, 202417
- Bellerophon Therapeutics (United States)SC 13G/A Mar 17, 2023 to Feb 14, 202418
- BioAtlaSC 13G/A Apr 28, 2022 to Feb 14, 202419
- Bolt Biotherapeutics, Inc.SC 13G/A Apr 20, 2023 to Feb 14, 202420
- Canton Strategic Holdings, Inc.SC 13G/A Dec 7, 2023 to Feb 14, 202421
- CytomX Therapeutics, Inc.SC 13G/A Jul 25, 2022 to Feb 14, 202422
- Elevation Oncology, Inc.SC 13G/A Feb 24, 2023 to Feb 14, 202423
- Evolus, Inc.SC 13G/A Feb 21, 2023 to Feb 14, 202424
- Genfit S.A.SC 13G/A May 1, 2023 to Feb 14, 202425
- IRulya Therapeutics Inc.SC 13G/A Mar 31, 2023 to Feb 14, 202426
- InflaRx N.V.SC 13G/A Apr 17, 2023 to Feb 14, 202427
- KalVista Pharmaceuticals, Inc.SC 13G/A May 26, 2022 to Feb 14, 202428
- Kinnate Biopharma Inc.SC 13G/A Nov 27, 2023 to Feb 14, 202429
- Lite Strategy, Inc.SC 13G/A May 1, 2023 to Feb 14, 202430
- Neuphoria Therapeutics Inc.SC 13G/A Oct 10, 2023 to Feb 14, 202431
- Pyxis Oncology, Inc.SC 13G/A Nov 4, 2022 to Feb 14, 202432
- REVIVA PHARMACEUTICALS HOLDINGS, INC.SC 13G/A Feb 14, 2023 to Feb 14, 202433
- TCR2 THERAPEUTICS INC.SC 13G/A Mar 4, 2022 to Feb 14, 202434
- Tarsus Pharmaceuticals, Inc.SC 13G/A May 13, 2022 to Feb 14, 202435
All 56 companies
- Tectonic Therapeutic, Inc.SC 13G/A Jun 6, 2023 to Feb 14, 202436
- Tonix PharmaceuticalsSC 13G/A Dec 27, 2022 to Feb 14, 202437
- Transcode Therapeutics, Inc.SC 13G/A Sep 26, 2023 to Feb 14, 202438
- bluebird bioSC 13G/A Jun 3, 2022 to Feb 14, 202439
- LENZ Therapeutics, Inc.SC 13G Feb 5, 202440
- Precision BioSciencesSC 13G Feb 5, 202441
- Rain Oncology Inc.SC 13D/A Jun 1, 2023 to Feb 2, 202442
- Ventyx Biosciences, Inc.SC 13G Jan 29, 202443
- Corbus PharmaceuticalsSC 13G Jan 26, 202444
- ASLAN Pharmaceuticals LtdSC 13G/A Feb 14, 2023 to Jan 2, 202445
- LianBioSC 13D Nov 1, 2023 to Nov 30, 202346
- Atea Pharmaceuticals, Inc.SC 13D/A May 22, 2023 to Nov 28, 202347
- Jounce TherapeuticsSC 13D/A Mar 6, 2023 to May 5, 202348
- ALBIREO PHARMA, INC.SC 13G/A Sep 26, 2022 to Feb 14, 202349
- Corvus Pharmaceuticals, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 202350
- HERON THERAPEUTICS, INC. /DE/SC 13G/A Feb 14, 2022 to Feb 14, 202351
- Inspirato IncSC 13G/A Feb 14, 202352
- Metacrine, Inc.SC 13G/A Dec 19, 2022 to Feb 14, 202353
- VERU INC.SC 13G/A Jun 6, 2022 to Feb 14, 202354
- Magenta TherapeuticsSC 13G Feb 13, 202355
- La Jolla Pharmaceutical CompanySC 13D/A Dec 2, 2021 to Aug 24, 202256
- Rocket Pharmaceuticals Inc.SC 13G/A Feb 14, 202257
- Vincerx Pharma, Inc.SC 13G/A Feb 14, 202258
- aTyr PharmaSC 13G/A Feb 14, 202259
- Aptevo Therapeutics Inc.SC 13D/A Nov 22, 2021 to Nov 26, 202160
- Odonate Therapeutics, Inc.SC 13D/A Nov 19, 202161
SEC filer profile
How TANG CAPITAL PARTNERS LP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARTANG CAPITAL PARTNERS LP1
- CIK0001191935
- Incorporated inDelaware1
- Fiscal year endsDecember 311
- Business address4747 Executive Drive, Suite 210, San Diego, CA 921211
- Phone858-200-38301
- On EDGAR sinceOct 1, 20021
- Filings609 in all: 4 (180), SC 13G/A (144), SC 13D/A (98), SC 13G (96), DFAN14A (29), 3 (21), SC 13D (17), PRRN14A (6)1
All 16 form types
5 (5), PREC14A (3), SCHEDULE 13G/A (3), 3/A (2), DEFC14A (2), 4/A (1), CORRESP (1), REGDEX (1)
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61